Jennifer H. Johnson

MicroRNA 132 regulates nutritional stress-induced chemokine production through repression of SirT1.

K. Waters, H. Xie, M. Waters, 2009, Molecular endocrinology.

Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580.

J. Parham, L. Frick, R. Crosby, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Rosiglitazone Induces Mitochondrial Biogenesis in Differentiated Murine 3T3-L1 and C3H/10T1/2 Adipocytes

K. Waters, T. Ryan, S. Witherspoon, 2011, PPAR research.

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

Ming-Chih Crouthamel, L. Harrington, T. Gilmer, 2007, Molecular Cancer Therapeutics.

The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation.

Rakesh Kumar, David M. Roberts, Jennifer H. Johnson, 2004, The American journal of pathology.

Discovery of 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a novel and potent vascular endothelial growth factor receptor inhibitor.

P. A. Harris, J. Veal, Rakesh Kumar, 2008, Journal of medicinal chemistry.

Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors.

P. A. Harris, J. Veal, Liping Wang, 2005, Journal of medicinal chemistry.

through Repression of SirT1 MicroRNA 132 Regulates Nutritional Stress-Induced Chemokine Production

H. Xie, M. Waters, Jennifer H. Johnson, 2009 .

The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation.

David M. Roberts, Joseph B. Kearney, V. Bautch, 2004, The American journal of pathology.